TotalMarketCap

Oric Pharmaceuticals

ORICNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$883.121 M

$8.52 -8.78%

Close of 6 Nov 2026

As of 6 Nov 2026, Oric Pharmaceuticals (ORIC) has a market capitalization of $883.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$129.5M

Loss-making

Shares outstanding

103,652,656

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #148Jade BiosciencesJBIO$896.1M
  2. #149Pharming GroupPHAR$884.9M
  3. #150Oric PharmaceuticalsORIC$883.1M
  4. #151Latigo BiotherapeuticsLTGO$865.9M
  5. #152Alto NeuroscienceANRO$861.0M

What if Oric Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$272,418.24

Per share 31,974× higher

Bitcoin $1.53T

$14,740.08

Per share 1,730× higher

Apple $5.02T

$48,390.30

Per share 5,680× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Oric Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.